Skip to main content
. 2022 Sep 9;101(36):e30532. doi: 10.1097/MD.0000000000030532

Figure 3.

Figure 3.

Associations between PPI use and OS in cancer patients treated with PD-1/L1 inhibitors. OS = overall survival, PD-1/L1 = programmed death protein-1/ligand 1, PPI = proton–pump inhibitor.